These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19836769)

  • 1. Editorial comment.
    Singer FR
    J Urol; 2009 Dec; 182(6):2676; dscussion 2676. PubMed ID: 19836769
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteoporosis treatment options expand.
    Mayo Clin Health Lett; 2010 Nov; 28(11):4. PubMed ID: 21158019
    [No Abstract]   [Full Text] [Related]  

  • 3. Denosumab (prolia) for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2010 Oct; 52(1349):81-2. PubMed ID: 21045756
    [No Abstract]   [Full Text] [Related]  

  • 4. Denosumab, osteoporosis, and prevention of fractures.
    Blackwood J
    N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950411
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comment to the status article about denosumab].
    Brasso K; Iversen P
    Ugeskr Laeger; 2011 Feb; 173(9):677; author reply 677. PubMed ID: 21473172
    [No Abstract]   [Full Text] [Related]  

  • 6. Denosumab.
    Rizzoli R; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2010 Aug; 9(8):591-2. PubMed ID: 20671758
    [No Abstract]   [Full Text] [Related]  

  • 7. Denosumab, osteoporosis, and prevention of fractures.
    Blythe SL
    N Engl J Med; 2009 Nov; 361(22):2189-90; author reply 2190-1. PubMed ID: 19950410
    [No Abstract]   [Full Text] [Related]  

  • 8. Study shows that a new type of osteoporosis drug reduces fracture risk.
    Harv Womens Health Watch; 2009 Oct; 17(2):6-7. PubMed ID: 19998553
    [No Abstract]   [Full Text] [Related]  

  • 9. ... Fracture prevention. New osteoporosis drug improves patient adherence.
    Jones KW; Bushardt RL
    JAAPA; 2010 Dec; 23(12):56, 60. PubMed ID: 21229838
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment.
    Ryan CW
    J Urol; 2009 Dec; 182(6):2675; dscussion 2676. PubMed ID: 19836773
    [No Abstract]   [Full Text] [Related]  

  • 11. Denosumab. Limited efficacy in fracture prevention, too many adverse effects.
    Prescrire Int; 2011 Jun; 20(117):145-8. PubMed ID: 21678700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection of hope.
    Elliott M
    Nurs Stand; 2010 Nov 10-16; 25(10):23. PubMed ID: 21155482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic bone diseases: translational research-preventing fractures with denosumab.
    Ebeling PR
    Nat Rev Rheumatol; 2009 Dec; 5(12):660-1. PubMed ID: 19946294
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate cancer: Androgen deprivation therapy and bone loss.
    Amir E; Tannock IF
    Nat Rev Urol; 2009 Dec; 6(12):642-4. PubMed ID: 19956194
    [No Abstract]   [Full Text] [Related]  

  • 15. What's new in treating older adults?
    Messinger-Rapport B
    Cleve Clin J Med; 2010 Nov; 77(11):770-90. PubMed ID: 21048051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab for bone metastases.
    Med Lett Drugs Ther; 2011 Jan; 53(1356):8. PubMed ID: 21252843
    [No Abstract]   [Full Text] [Related]  

  • 17. Denosumab, osteoporosis, and prevention of fractures.
    Kyrgidis A
    N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950409
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing metastases to bone: denosumab or bisphosphonates?
    Nanes MS
    J Bone Miner Res; 2010 Mar; 25(3):437-9. PubMed ID: 20200989
    [No Abstract]   [Full Text] [Related]  

  • 19. Denosumab findings in metastatic breast cancer.
    Stopeck A
    Clin Adv Hematol Oncol; 2010 Mar; 8(3):159-60. PubMed ID: 20400929
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone-modifying agents in the treatment of advanced cancer.
    Ritchie KL
    S D Med; 2011 May; 64(5):167-8. PubMed ID: 21661342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.